Full Text View
Tabular View
No Study Results Posted
Related Studies
Therapy of Pulmonary Arterial Hypertension (PAH) - Treatment With Sildenafil in Eisenmenger Patients
This study has been terminated.
Study NCT00586794   Information provided by Competence Network for Congenital Heart Defects

First Received on December 21, 2007.   Last Updated on June 5, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Eisenmenger Complex
Hypertension
Hypertension, Pulmonary
More general conditions related to this trial
Cardiovascular Abnormalities
Cardiovascular Diseases
Congenital Abnormalities
Heart Defects, Congenital
Heart Diseases
Lung Diseases
Respiratory Tract Diseases
Vascular Diseases
Interventions listed in this trial
Sildenafil
Placebo
More general drug interventions related to this trial
Cardiovascular Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Phosphodiesterase 5 Inhibitors
Phosphodiesterase Inhibitors
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
Competence Network for Congenital Heart Defects
German Federal Ministry of Education and Research


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services